ENDRA Life Sciences Inc. NDRA
NASDAQ · United States · Health Technology
$6.06+0.18 (+3.06%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -1.17 | -0.84 | -39.3% | +0.4%$4.47→$4.49 |
| Q1 2026 | 2026-05-15 | -1.09 | -1.23 | +11.4% | -5.7%$5.74→$5.41 |
| Q4 2025 | 2026-03-31 | -2.23 | -1.23 | -81.3% | -0.6%$4.68→$4.65 |
| Q3 2025 | 2025-11-14 | -2.10 | -1.95 | -7.7% | -5.6%$6.57→$6.20 |
| Q1 2025 | 2025-05-15 | -1.86 | -3.91 | +52.4% | — |
| Q4 2024 | 2025-03-31 | 25.20 | -4.10 | +714.6% | — |
| Q3 2024 | 2024-11-15 | -9.54 | -62.30 | +84.7% | — |
| Q2 2024 | 2024-08-14 | -140.00 | -122.50 | -14.3% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.